The subjects were assigned to receive either atovaquone (750 mg every 12 hours) and azithromycin (500 mg on day 1 and 250 mg per day thereafter) for seven days (40 subjects) or clindamycin (600 mg ...

Participants were randomized to receive either two 3-g doses of gepotidacin (n=202) or an intramuscular injection of ceftriaxone 500 mg plus 1 g of oral azithromycin (n=204).

Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. We conduct ...

In both groups, patients received lansoprazole 30 mg p.o. twice daily on day 1 and, on days 2 and 3, lansoprazole 30 mg p.o. twice daily, amoxicillin 1 g (of anhydrous amoxicillin) p.o. twice ...

British drugmaker GSK said on Monday its oral drug to treat gonorrhoea met the main goal of non-inferiority, compared to an existing combination treatment, in a late-stage trial. Skip to main content ...